Alison Horstmeyer discusses how pharma executives can apply four attributes of curiosity to negotiate VUCA (volatile, uncertain, complex, and ambiguous) conditions and improve organizational outcomes.

Forbes contributors publish independent expert analyses and insights. Taking a deeper look at the art and science of leadership. Mar 11, 2020, 10:38am EDT Mar 11, 2020, 10:38am EDT This article is ...

Wherever we look around us, we find claims and concerns that the world is increasingly getting out of control. Whether it is the business press, the media more generally, or our personal conversations ...

The acronym “Vuca”—which stands for volatility, uncertainty, complexity, and ambiguity—was originally introduced by military analysts to describe the state of the world at the end of the Cold War. It ...